International Myeloma Foundation
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest global organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.Your support helps us provide a wide range of programs and services to the myeloma community in the areas of Research, Education, Support, and Advocacy.
The International Myeloma Foundation is a 501(c)(3) organization.
Learn more at www.myeloma.org
- 4:30
- 10 сағат бұрын
MajesTEC-1: Longer Follow-up Teclistamab + Tocilizumab Prophylaxis for CRS in RR multiple myeloma
- 2:12
- 10 сағат бұрын
Jerry's CAR T-Cell Therapy Experience: From Preparation to Procedure | Living Well with Myeloma
- 59:50
- 17 сағат бұрын
IMWG Conference Series 2024: Making Sense of Treatment
- 6:19
- 20 сағат бұрын
Linvoseltamab for RR Multiple Myeloma: Deep, Durable Responses at 14-Month Follow-Up (LINKER-MM1)
- 3:26
- 20 сағат бұрын
What does the FDA approval of MRD testing for myeloma mean for patients and drug development?
- 16:46
- 22 сағат бұрын
Idecabtagene Vicleucel for High-Risk Early Relapse Multiple Myeloma - KarMMa-2 Study
- 14:31
- 22 сағат бұрын
Isatuximab + Len/Dex/Bortezomib vs IsaRd in Newly Diagnosed Transplant Ineligible Multiple Myeloma
- 12:37
- Күн бұрын
Isa-VRd vs VRd for Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (IMROZ)
- 15:46
- Күн бұрын
DREAMM-8: Belantamab mafodotin + pomalidomide and dex shows improved outcomes in RR multiple myeloma
- 4:04
- Күн бұрын
The IMF Iceland Cycling Expedition (ICE): A Journey to End Myeloma | An Interview with Shawn Twigg
- 0:16
- 14 күн бұрын
A Rigorous Journey to End Myeloma | The Iceland Cycling Expedition to Fund Myeloma Research
- 1:14
- 14 күн бұрын
Experts Gather at the International Myeloma Foundation IMWG Summit to Improve Patients' Lives
- 7:07
- 14 күн бұрын
Improved Depth of Response and MRD Negativity with DARA + VRd in Transplant-Eligible NDMM: PERSEUS
- 3:00
- 14 күн бұрын
International Myeloma Foundation's 15th Annual Gala Raised Nearly $700K to Support Myeloma R...
- 5:32
- 21 күн бұрын
Myeloma Made Simple: Bispecific Antibody Targets Made Simple | Myeloma Targeting with Bispecifics
- 6:17
- 28 күн бұрын
Myeloma Made Simple: Bispecific Antibodies Made Simple | Bispecific Antibodies for Myeloma Treatment
- 3:34
- Ай бұрын
Empower Yourself with Myeloma Support Groups: Jerry and Jill's Journey from Participants to ...
- 2:42:35
- Ай бұрын
Virtual Regional Community Workshop (RCW) - Mid Atlantic
- 5:10
- Ай бұрын
Myeloma Made Simple: Xpovio (Selinexor) Side Effect Management Made Simple | Managing Side Effects
- 5:08
- Ай бұрын
Пікірлер